Primary Completion Date and Study Completion Date Answer Different Questions

Signals to watch

• A group post cites one completion date without naming the outcome or adverse-event scope
• A screenshot shows an estimated or actual date but omits record history
• A claimed disclosure deadline has no named law, policy or study-applicability test

Primary Completion Date and Study Completion Date are not two labels for the same event. On ClinicalTrials.gov, the first marks final data collection for all primary outcome measures. The second marks final data collection for primary and secondary outcome measures and adverse events. Neither field, read alone, proves that results are overdue, that a sponsor is noncompliant or that a disclosure-services project exists.

This distinction matters to a clinical-operations intelligence analyst reviewing authorised sponsor-operations, clinical-operations and research-vendor Telegram groups. If a post says “primary complete last month, who can fix disclosure?”, seeing it a day late may mean missing the vendor shortlist. Treating the phrase as a confirmed deadline can produce a worse error: the analyst may route the wrong study, rule and deliverable to sales.

Key facts before reading a deadline into either field

• Primary Completion Date covers final data collection for all primary outcome measures.
• Study Completion Date also covers secondary outcome measures and adverse events.
• Each date distinguishes an anticipated value from an actual value.
• Primary Completion may precede Study Completion without indicating an error.
• Neither milestone alone establishes a results-submission deadline or a service requirement.
• The exact record, date type, version history, reporting basis and requester authority still require verification.

Definition: the dates close different data-collection clocks

ClinicalTrials.gov’s Protocol Registration Data Element Definitions defines Primary Completion Date as the date on which the final participant was examined or received an intervention for the purposes of final collection of data for the primary outcome measures. When primary outcomes finish on different dates, the field refers to completion of data collection for all primary outcomes.

The same official page defines Study Completion Date as the date on which the final participant was examined or received an intervention or treatment for final collection of data for the primary and secondary outcome measures and adverse events. The difference is the data scope, not a judgement that one date is more important.

Both fields distinguish an anticipated date from an actual date. The anticipated date is a forecast. Once the milestone occurs, the Responsible Party updates the field with the actual date. A screenshot that omits the type can therefore hide a material part of the record.

Why Primary Completion can come first

A study can finish collecting data for its primary outcomes while continuing secondary-outcome assessment and adverse-event collection. That sequence makes the Primary Completion Date earlier than the Study Completion Date without indicating an error. Other protocol follow-up may continue too, but the official Study Completion Date definition is tied specifically to primary and secondary outcome measures and adverse events.

The Results Data Element Definitions also treats outcome measures and adverse events as separate result modules. A public record may therefore contain four different questions:

1. Has final data collection for every primary outcome finished?
2. Has final data collection for secondary outcomes and adverse events finished?
3. Have results modules been submitted and posted?
4. Does a named reporting requirement apply to this study and milestone?

Only the first two are answered by the two completion-date fields. The date pair does not answer the other two.

Example: “primary complete” does not identify the work

Consider this illustrative composite thread, not a real sponsor, customer request or commercial result:

primary complete in July. ctgov results still blank. need a disclosure vendor asap

Twenty minutes later, another participant writes:

follow-up runs to Nov I think. not sure which NCT, old CRO has the record

The first fragment contains a milestone claim and a visible-page observation. The second introduces a possible later Study Completion Date plus unresolved record access. Missing facts include the NCT number, whether “July” is estimated or actual, which outcomes finished, the applicable reporting route, the Responsible Party, current submission status and whether the poster can procure services.

The correct first note is not “late results opportunity.” It is: claimed Primary Completion in July; later follow-up may continue; exact record, date type, reporting basis and record owner unverified. That wording preserves the useful clue without turning it into a compliance or sales conclusion.

A two-clock interpretation note

Use five lines when a completion date appears in a candidate Signal:

• Exact object: NCT number or record URL, plus the field name as displayed.
• Date and type: the submitted date and whether the definition identifies it as anticipated or actual.
• Outcome scope: primary outcomes only, or primary plus secondary outcomes and adverse events.
• History: whether an earlier version displayed a different date or type.
• Reporting basis: the named law, policy or other requirement offered for any claimed deadline.

This is an editorial review note, not a ClinicalTrials.gov form or official compliance method. Its value is the stop condition: if the record, field or reporting basis is missing, do not calculate lateness from the message.

The ClinicalTrials.gov disclosure evidence map expands the check to the record owner, protocol objects and result modules. When the date itself changed, use the record-history navigation steps to identify the visible version before asking why it changed. The official-source ladder helps keep a copied deadline separate from the authority that could support it.

Top Prospect can organise matching messages from groups a user deliberately connects, is authorised to access and has enabled, preserving the original text, source, time, AI summary and review reasons. Its current production matching-target interface saves configurations but does not automatically generate new candidates. It cannot determine legal applicability, certify a deadline, verify the poster or contact study participants. The authorised-source workflow shows where human review begins.

Where the dates stop being evidence

The official Clinical Trial Reporting Requirements page lists multiple laws, policies and funder or journal requirements. That is why one public milestone cannot serve as a universal deadline calculator. Applicability can depend on study type, jurisdiction, product status, sponsor or funder conditions and other facts not supplied by a Telegram fragment.

The date fields also do not identify who changed the record, why a forecast moved, whether an earlier entry was wrong, who controls the Protocol Registration and Results System account, or whether a group participant is authorised to buy services. Those are separate workflow and identity checks. Stop the date analysis there until an exact record, version and reporting basis are available.

Frequently asked questions

Is Primary Completion Date the date when the whole study ends?

Not necessarily. It is the date when final data collection for all primary outcome measures is complete. Data collection for secondary outcomes and adverse events can continue until the Study Completion Date.

Does Study Completion Date prove that ClinicalTrials.gov results are due?

No. It is a study milestone. A results deadline requires the applicable law or policy, study facts and any relevant conditions; the public date alone does not perform that assessment.

Why can a completion date change from anticipated to actual?

ClinicalTrials.gov requires an anticipated date before the milestone and an actual date after it occurs. The record history can show how the submitted value changed.

Can Top Prospect decide that a completion date creates a sales opportunity?

No. It can organise matching fragments from authorised enabled sources and retain their evidence for review. A person must verify the study, applicable requirement, requester and service need.

Sources and further reading

• ClinicalTrials.gov: Protocol Registration Data Element Definitions for Interventional and Observational Studies, accessed 24 August 2026↗
• ClinicalTrials.gov: Results Data Element Definitions for Interventional and Observational Studies, accessed 24 August 2026↗
• ClinicalTrials.gov: Clinical Trial Reporting Requirements, accessed 24 August 2026↗

RESEARCH & DEFINITIONS

How a Signal worth attention is found

See how Top Prospect finds and organizes Signals worth checking, keeps the original Telegram context, removes duplicates, and helps you decide what to review first. You decide whether to follow up and what to do next.

Open the methodology and core definitions →